Kulkarni S K, Verma A
Department of Pharmaceutical Sciences, Panjab University, Chandigarh, India.
Indian J Exp Biol. 1992 Oct;30(10):885-8.
Chronic treatment with BR-16A (20-500 mg/kg) followed by saline on days 1 to 9 failed to produce any significant change in tail-flick latency from the saline-pretreated group in mice. Repeated administration of BR-16A(20-500 mg/kg) for 9 days however, attenuated the development of tolerance to the analgesic effect of morphine (10 mg/kg). BR-16A (20-500 mg/kg) also suppressed, in a dose-dependent manner, the development of morphine dependence as assessed by naloxone (2 mg/kg)-precipitated withdrawal on day 10 of testing.
在第1至9天用BR - 16A(20 - 500毫克/千克)进行慢性治疗,随后注射生理盐水,与生理盐水预处理组相比,小鼠的甩尾潜伏期未产生任何显著变化。然而,连续9天重复给予BR - 16A(20 - 500毫克/千克)可减弱对吗啡(10毫克/千克)镇痛作用的耐受性发展。通过第10天测试时纳洛酮(2毫克/千克)诱发的戒断反应评估,BR - 16A(20 - 500毫克/千克)还以剂量依赖的方式抑制了吗啡依赖性的发展。